EVALUATION OF HUMAN EXPOSURE TO HEXACHLOROBENZENE AT SAMARITÁ, SÃO VICENTE, SÃO PAULO, BRAZIL

Na área de Samaritá, cidade de São Vicente, São Paulo, Brasil, resíduos químicos industriais foram descartados por vários anos, sem proteção ambiental, contendo 55 a 85% de hexaclorobenzeno (HCB) e outros produtos em menores quantidades. Para avaliar o impacto à saúde foram analisados soro sangüíneo de 234 pessoas de diversos bairros da região, com mais de 2 anos de residência, subdivididos em 6 setores: A - Quarentenário e vizinhança do lixo industrial a 67 km; B - Jardim Rio Branco; C - Parque das Bandeiras; D - Gleba II; E - Vila Samaritá; F - Vila Ema, Vila Iolanda, Vila Mathias. Dez amostras de soro sangüíneo de habitantes de Itanhaém, área considerada não exposta, foram coletados para fornecer dados de referência. HCB não foi encontrado em nenhuma destas amostras. Resíduos de HCB foram analisados por cromatografia a gás com detetor de captura de elétrons e limite de determinação de 0,02 µg/dL. Os níveis médios de HCB no soro sanguíneo dos moradores mostraram-se significativamente diferentes (p < 0.001) entre o setor A (0.41µg/dL) e os demais setores: B (0.04 µg/dL); C (0.04 µg/ dL); D (0.03 µg/dL); E (0.04 µg/dL): F (0.04 µg/dL). Ainda que não seja possível estabelecer correlações com doenças encontradas na população, este estudo demonstra que os resíduos de HCB constituem problema para a saúde, pois além de contaminar o meio ambiente são encontrados em seres vivos, inclusive no ser humano. Abstract In the Samaritá area of São Vicente city, São Paulo State, Brazil, a chemical industry discarded for several years, with no environmental protection, a mixture of residues containing 55 to 85% of hexachlorobenzene (HCB) and others in smaller quantities. In order to evaluate the impact of these residues on the health of the local population, blood serum samples taken from 234 people dwelling at several quarters of this area for over two years were analyzed, divided into 6 sectors: A - Quarentenário and neighborhood of the industrial wastes dump at 67-km; B - Jardim Rio Branco; C - Parque das Bandeiras; D - Gleba II; E -Vila Samaritá; F -Vila Ema, Vila Iolanda, Vila Mathias. Ten blood samples from residents of an area considered no exposed from Itanhaém city were collected to provide baseline information and HCB was not found in any of the samples. HCB residues were analysed by gas chromatography with an electron capture detector, with a determination limit of 0.02 µg/dL. The mean of HCB in blood serum for the inhabitants of the affected area presented significant differences (p < 0.001) between sector A (0.41 µg/dL) and all the others sectors: B (0.04 µg/dL); C (0.04 µg/ dL); D (0.03 µg/dL); E (0.04 µg/dL): F (0.04 µg/dL). Although it has not yet been possible to correlate such findings with the presence of diseases among the area inhabitants, this study indicates that the HCB residues are a health risk, as they not only contaminate the environment, but are also present at the biota, including humans

Pd-Impregnated activated carbon and treatment acid to remove sulfur and nitrogen from diesel

ABSTRACT Removal of sulfur and nitrogen compounds from national commercial diesel through adsorption onto activated carbon was studied. Brazilian commercial activated carbon samples (AC) were modified by acid oxidation and, alternatively, were impregnated with palladium chloride. Modified carbon samples showed a significant increase in the quantity of acid sites, particularly those AC submitted to impregnation with palladium. Adsorption capacity of the carbon samples increased proportionally to the increase in the acid groups. Adsorption efficiency of the activated carbon impregnated with palladium chloride was over 85% for nitrogen compounds and over 60% for sulfur compounds. The treatment studied was found to be an efficient option for the removal of sulfur and nitrogen compounds present in commercial diesel, and thus it could be an alternative pretreatment in the conventional hydrotreatment process

Transcriptome profiling of sheep granulosa cells and oocytes during early follicular development obtained by Laser Capture Microdissection

<p>Abstract</p> <p>Background</p> <p>Successful achievement of early folliculogenesis is crucial for female reproductive function. The process is finely regulated by cell-cell interactions and by the coordinated expression of genes in both the oocyte and in granulosa cells. Despite many studies, little is known about the cell-specific gene expression driving early folliculogenesis. The very small size of these follicles and the mixture of types of follicles within the developing ovary make the experimental study of isolated follicular components very difficult.</p> <p>The recently developed laser capture microdissection (LCM) technique coupled with microarray experiments is a promising way to address the molecular profile of pure cell populations. However, one main challenge was to preserve the RNA quality during the isolation of single cells or groups of cells and also to obtain sufficient amounts of RNA.</p> <p>Using a new LCM method, we describe here the separate expression profiles of oocytes and follicular cells during the first stages of sheep folliculogenesis.</p> <p>Results</p> <p>We developed a new tissue fixation protocol ensuring efficient single cell capture and RNA integrity during the microdissection procedure. Enrichment in specific cell types was controlled by qRT-PCR analysis of known genes: six oocyte-specific genes (<it>SOHLH2</it>, <it>MAEL</it>, <it>MATER</it>, <it>VASA</it>, <it>GDF9</it>, <it>BMP15</it>) and three granulosa cell-specific genes (<it>KL</it>, <it>GATA4</it>, <it>AMH</it>).</p> <p>A global gene expression profile for each follicular compartment during early developmental stages was identified here for the first time, using a bovine Affymetrix chip. Most notably, the granulosa cell dataset is unique to date. The comparison of oocyte vs. follicular cell transcriptomes revealed 1050 transcripts specific to the granulosa cell and 759 specific to the oocyte.</p> <p>Functional analyses allowed the characterization of the three main cellular events involved in early folliculogenesis and confirmed the relevance and potential of LCM-derived RNA.</p> <p>Conclusions</p> <p>The ovary is a complex mixture of different cell types. Distinct cell populations need therefore to be analyzed for a better understanding of their potential interactions. LCM and microarray analysis allowed us to identify novel gene expression patterns in follicular cells at different stages and in oocyte populations.</p

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Microbiota-host-diet interactions contribute to the development of metabolic diseases. Imidazole propionate is a novel microbially produced metabolite from histidine, which impairs glucose metabolism. Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from three European countries have elevated serum imidazole propionate levels. Furthermore, imidazole propionate levels were increased in subjects with low bacterial gene richness and Bacteroides 2 enterotype, which have previously been associated with obesity. The Bacteroides 2 enterotype was also associated with increased abundance of the genes involved in imidazole propionate biosynthesis from dietary histidine. Since patients and controls did not differ in their histidine dietary intake, the elevated levels of imidazole propionate in type 2 diabetes likely reflects altered microbial metabolism of histidine, rather than histidine intake per se. Thus the microbiota may contribute to type 2 diabetes by generating imidazole propionate that can modulate host inflammation and metabolism

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks